A pathological complete response to neoadjuvant chemotherapy and immunotherapy in a non-small cell lung cancer patient

Lung cancer is the leading cause of cancer-related mortality worldwide. Patients with locally advanced non-small cell lung cancer (NSCLC) have lower overall survival. Studies have shown that some patients with unresectable stage III NSCLC develop disease progression after initial chemoradiotherapy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Pengqiang, Chen, Hao, Zeng, Taidui, Wu, Weidong, Xu, Guobing, Xu, Chi, Zheng, Bin, Zhu, Yong, Zheng, Wei, Chen, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653127/
https://www.ncbi.nlm.nih.gov/pubmed/33209635
http://dx.doi.org/10.21037/tlcr-20-770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653127/
https://www.ncbi.nlm.nih.gov/pubmed/33209635
http://dx.doi.org/10.21037/tlcr-20-770

Ejemplares similares